- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03167931
Neuromodulation by Non-invasive Brain Stimulation (NEUROMOD)
Neuromodulation by Non-invasive Brain Stimulation (NEUROMOD)
The main objective of this study is to estimate the effect of the neuromodulation on the behavioral performances during the access in semantics according to the age of the individuals.
Neuromodulation by non-invasive stimulation allows to explore the functioning of the brain by exciting or by inhibiting localized cortical zones. The modulation of the performances in cognitive tasks, further to the neuromodulation of these zones, allows to deduce on their functional roles.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Grenoble, Frankrijk, 38043
- Werving
- CHU
-
Contact:
- Laurent TORLAY
- E-mail: laurent.torlay@univ-grenoble-alpes.fr
-
Contact:
- Thierry BOUGEROL
- E-mail: TBougerol@chu-grenoble.fr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Major healthy Subject ( 18 - 85 years)
- Right-hander
- Signed Informed consent
- A medical examination must be made before the participation for the research
- Membership in or beneficiary of a national insurance scheme
Non inclusion Criteria:
- Subject under age 18 and of more than 85 years.
- Contraindications in the practice of MRI, TMS and tES
- Existence of a severe affection on the general plan: cardiac, respiratory, hematological, renal, hepatic, cancerous
- Regular taking of anxiolytic, sedative, antidepressant, neuroleptic
- Characterized psychiatric pathology
- Ingestion of alcohol before the examination
- Pregnancy, parturiency or breast-feeding
- Private person of freedom by court or administrative order, nobody being the object of a legal protective measure (under guardianship or guardianship)
- Participation to other protocols of current search with period of exclusion or in the previous week
- Subject which would perceive more than 4500 euros of compensation because of its participation in other searches involving the human person in 12 months preceding this study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: 18-49 years group
Participants undergo 2 sessions of MRI + transcranial Magnetic Stimulation or transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
|
Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
|
|
Experimenteel: 50-85 years group
Participants undergo 2 sessions of MRI + transcranial Magnetic Stimulation or transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
|
Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram.
The 2 sessions are performed with an interval of 3 to 7 days.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Effect of the neuromodulation on the behavioral performances during the access in semantics
Tijdsspanne: 3 hours
|
Evaluation of the changes of the behavioral performances before and after the neuromodulation by non-invasive cortical stimulation according to the age.
More exactly, the investigators shall compare response times before and after neuromodulation between both age groups (18-49 years and 50-85 years), by testing the interaction between the effect of the neuromodulation and the age.
|
3 hours
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Estimate the effect of the neuromodulation on the behavioral performances
Tijdsspanne: 3 hours
|
Compare the percentages of correct answers before and after neuromodulation by non-invasive cortical electric stimulation, according to the age (18-49 years vs 50-85 years).
|
3 hours
|
|
Estimate the effect of transcranial Electrical Stimulation (tES) on the cognitive performances by neuropsychological scores, according to the age.
Tijdsspanne: 3 hours
|
Comparison of the neuropsychological scores before and after tES, according to the age (18-49 years vs 50-85 years).
|
3 hours
|
|
Estimate the effect of tES on the cerebral functional activity, by comparing blood-oxygen-level dependent (BOLD ) signal or functional MRI before and after tES according to the age (18-49 years vs 50-85 years).
Tijdsspanne: 3 hours
|
The investigators extract estimates parameters (Estimated Beta weight Values) corresponding to each tES stimulation.
Each session is be designed by using general linear model (Friston, 1998, statistical parametrical mapping in fMRI) defined as Ybefore tES = R1Beta1+R2Beta2 +R0Beta0 + e and Yafter tES = R1Beta1 +R2Beta2 +R0Beta0 + e, with Y = acquired BOLD signal, e = error, R1Beta1 corresponding to the task (meaning interest activation) regressor and R2Beta2 corresponding to the control (meaning no interest activation) regressor respectively convolved with the canonical hemodynamic response function (cHRf) and R0B0 corresponding to the constant regressor.
Parameter estimates are calculated by extracting Beta1 and Beta2 values for each session respectively in order to compute statistical comparison (measure by subject) on the outcome measure (Beta1 before tES - Beta1 after tES).
|
3 hours
|
|
Estimate the effect of the Transcranial Magnetic Stimulation (TMS) on the cognitive performances by neuropsychological scores, according to the age.
Tijdsspanne: 3 hours
|
Comparison of the neuropsychological scores before and after Transcranial Magnetic Stimulation (TMS), according to the age (18-49 years vs 50-85 years).
|
3 hours
|
|
Estimate the effect of the TMS on the intellectual functional activity, according to the age.
Tijdsspanne: 3 hours
|
Comparison of the cerebral functional activity (electric neuronal signal, EEG) before and after TMS, according to the age (18-49 years vs 50-85 years).
|
3 hours
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14.
- Zimerman M, Hummel FC. Non-invasive brain stimulation: enhancing motor and cognitive functions in healthy old subjects. Front Aging Neurosci. 2010 Dec 1;2:149. doi: 10.3389/fnagi.2010.00149. eCollection 2010.
- Holland R, Leff AP, Josephs O, Galea JM, Desikan M, Price CJ, Rothwell JC, Crinion J. Speech facilitation by left inferior frontal cortex stimulation. Curr Biol. 2011 Aug 23;21(16):1403-7. doi: 10.1016/j.cub.2011.07.021. Epub 2011 Aug 4.
- Monti A, Ferrucci R, Fumagalli M, Mameli F, Cogiamanian F, Ardolino G, Priori A. Transcranial direct current stimulation (tDCS) and language. J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):832-42. doi: 10.1136/jnnp-2012-302825. Epub 2012 Nov 8.
- Liuzzi G, Freundlieb N, Ridder V, Hoppe J, Heise K, Zimerman M, Dobel C, Enriquez-Geppert S, Gerloff C, Zwitserlood P, Hummel FC. The involvement of the left motor cortex in learning of a novel action word lexicon. Curr Biol. 2010 Oct 12;20(19):1745-51. doi: 10.1016/j.cub.2010.08.034. Epub 2010 Sep 30.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- 38RC17.078
- 2017-A00834-49 (Andere identificatie: ansm)
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezond
-
University Hospital, GhentWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Herhaaldelijk negatief denkenBelgië
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Borderline persoonlijkheidsstoornis (BPS)Verenigde Staten
-
Hacettepe UniversityWervingBronchiëctasie Volwassene | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
Hasselt UniversityWervingMultiple sclerose | Healthy Controls Group - Leeftijd en geslacht afgestemdBelgië, Italië, Spanje
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brain and Behavior...WervingOpioïdengebruiksstoornis | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University of North Carolina, Chapel HillNational Institute of Neurological Disorders and Stroke (NINDS)WervingMusculoskeletale pijn | Fibromyalgie | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
Gulseren Demir KarakilicVoltooidFibromyalgie Syndroom | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk
-
Abant Izzet Baysal UniversityVoltooidHealthy Controls Group - Leeftijd en geslacht afgestemd | Ziekte van Alzheimer (AD)Turkije (Türkiye)
Klinische onderzoeken op MRI + transcranial Magnetic Stimulation
-
VA Office of Research and DevelopmentJoseph Maxwell Cleland VA Medical CenterWervingHartinfarct | Vermoeidheid | Beroerte, chronischVerenigde Staten
-
Medical University of South CarolinaWervingHartinfarct | Gevolgen van een beroerte | Motivatie | Apathie | Beroerte/hersenaanval | Beroerte/cerebrovasculair accident (ischemisch of hemorragisch) | AbuliaVerenigde Staten
-
University Hospital, Strasbourg, FranceWervingDementie met Lewy Bodies-diagnose | Aanzienlijke cognitieve fluctuaties in DLBFrankrijk
-
Maastricht University Medical CenterVoltooid
-
King's College LondonVoltooidVreetbui syndroomVerenigd Koninkrijk
-
Hospital Universitari Vall d'Hebron Research InstituteVoltooidAutisme Spectrum Stoornis | Aandachtstekortstoornis met hyperactiviteitSpanje
-
Minneapolis Veterans Affairs Medical CenterCenter for Veterans Research and EducationVoltooidObesitas | Impulsiviteit | Dwangmatig te veel etenVerenigde Staten
-
University of ValenciaAanmelden op uitnodigingProdromale ziekte van AlzheimerSpanje
-
University of RochesterBrain & Behavior Research FoundationVoltooid
-
Johns Hopkins UniversityUniversity of Texas at Austin; Baszucki Brain Research Fund; Magnus MedicalVoltooid